NASDAQ
Genmab A/S (GMAB) has a current ratio of 2.02x as of Monday, May 25, 2026. This represents a 83.35% decrease compared to its 12-month average of 12.14x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.